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BackgroundaaParaneoplastic neurological disorders associated with anti-Ri-antibodies, which 
are typically present with opsoclonus-myoclonus-ataxia. Most cases with anti-Ri-antibodyasso-
ciated paraneoplastic syndrome due to breast cancer occur in women - its occurrence in men is 
extremely rare. 
Case ReportaaWe present herein the case of a male patient with breast cancer who had atypical 
anti-Ri-antibody-associated paraneoplastic syndrome presenting as complete horizontal ophth-
almoplegia, left trigeminal sensory symptoms, and truncal ataxia. Following the diagnosis of 
paraneoplastic syndrome, chemotherapy and immunomodulating treatment including intrave-
nous immunoglobulin and oral prednisolone were administered. Although the patient was ne-
gative for serum anti-Ri-antibodies 14 weeks later, his symptoms persisted.   
ConclusionsaaTo our knowledge, this is the first case report of ophthalmoplegia without op-
soclonus-myoclonus in a male anti-Ri-antibody-positive patient with breast cancer. 
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Paraneoplastic neurological disorders associated with anti-Ri-
antibodies (also known as anti-neuronal nuclear antibodies 
type II) mainly present with opsoclonus-myoclonus-ataxia.
1       
Ophthalmoplegia without opsoclonus is very rare.
2,3 Although 
anti-Ri-antibodies have been reported in patients with gyneco-
logical tumors and small-cell lung cancer,
1,4 they are mostly 
identified in patients with breast cancer. Most cases due to 
breast cancer occur in women. Its occurrence in men is ex-
tremely rare; there is thus far only one reported case, in which 
paraneoplastic opsoclonus-myoclonus was found in a man 
with breast cancer and anti-Ri-antibodies.
5 We present herein 
the case of a male patient with breast cancer who had atypical 
anti-Ri-antibody paraneoplastic syndrome presenting as com-
plete horizontal ophthalmoplegia, left trigeminal sensory symp-




A 52-year-old man was referred to a hospital with subacute 
onset of binocular diplopia, left facial numbness, and gait 
disturbance. He was diagnosed with breast cancer 1 month 
after the onset of symptoms and then underwent a right mod-
ified radical mastectomy to remove an invasive ductal car-
cinoma. Neurologic examination revealed left trigeminal hy-
pesthesia and complete horizontal gaze palsy without ops-
oclonus-myoclonus. His motor strength and deep tendon re-
flexes were normal. Sensation was intact to all modalities. 
The patient exhibited a wide-based gait and could not per-
form tandem gait. His cerebrospinal fluid showed normal 
cell counts and protein values, and negative cytology and viral 
markers. Immunofluorescence analysis revealed that the pa-
tient’s serum contained anti-Ri-antibodies ( serial dilutions 
revealed a specific antibody titer of 1 : 60), and was negative 
for anti-Hu, anti-Yo, and neuromyelitis optica antibodies. A 
brain magnetic resonance imaging (MRI) scan revealed a 
high-signal-intensity lesion in the pontine tegmentum that was 
not enhanced with gadolinium (Fig. 1). A brain magnetic re-
sonance angiogram showed no significant steno-occlusive le-
sion. Initial infusion of intravenous immunoglobulins (400 
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symptom onset, followed by a maintenance dose (400 mg/ 
kg/day) every 2 months for 1 year. Concurrent chemotherapy 
of doxorubicin, cyclophosphamide, and dexamethasone was 
administered. After four cycles of chemotherapy, the patient’s 
serum tested negative for anti-Ri-antibodies, and a follow-up 
brain MRI showed neither abnormal signal change nor atro-
phy in the brainstem. Further extensive searching, including 
whole-body positron-emission tomography, produced no evi-
dence of tumor recurrence. However, this patient’s neurolo-
gical deficit has persisted during the subsequent 3-year fol-





Whilst opsoclonus-myoclonus ataxia syndrome is often used 
to describe anti-Ri-antibody-associated paraneoplastic dis-
order, it has a wide spectrum of neurological manifesta-
tions.
6,7 The present case emphasizes the clinical heteroge-
neity of this disorder. However, even in the absence of opso-
clonus, oculomotor dysfunction is usually prominent,
8,9 and 
the brainstem is a major site of autoimmunity. The main cli-
nical features in our patient were brainstem syndrome involv-
ing the structures of the dorsal pons: the parapontine reti-
cular formation, abducens nucleus, medial longitudinal fasci-
culus, and trigeminal nucleus of the spinal tract. 
In anti-Ri-antibody-positive patients, brain MRI findings 
are usually normal, with only a few exceptions. There are 
reports of an abnormal signal in the dorsal midbrain,
10 and 
atrophy of the cerebellar vermis
1 on brain MRI, associated 
with anti-Ri-antibodies. In our patient, MRI disclosed sym-
metric hyperintense lesions in the dorsal pons that were rever-
sible with treatment. However, his symptoms persisted even 
after the lesion had disappeared. Tumor removal and chemo-
therapy did not improve the paraneoplastic abnormalities 
and the effect of immunoglobulin was also disappointing. 
Thus, it appears that irreversible, rather than functional damage 
to the neurons causes the symptoms of anti-Ri-antibody-as-
sociated paraneoplastic syndrome. 
The underlying tumor in our case was an invasive ductal 
cell carcinoma of the breast. The incidence of breast caner in 
man is low in the literature, representing approximately 1% 
of all breast cancer diagnoses.
11 To our knowledge, this is the 
first case report of ophthalmoplegia without opsoclonus-myo-
clonus in a male, anti-Ri-antibody-positive patient with breast 
cancer. The findings of this case support the differentiation 
of anti-Ri-antibody-associated paraneoplastic syndrome even 
in the absence of opsoclonus, and that it can also occur in 
male patients with breast cancer. 
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Fig. 1. T2-weighted magnetic resonance images showing bilat-
eral symmetric hyperintense lesions in the pontine tegmentum. A:
Parapontine reticular formation (arrow) in the lower pons. B: Me-
dial longitudinal fasciculus (arrow) in the mid pons. 
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